Healthcare -
Biotechnology - NASDAQ - US
$ 1.645
-16.5 %
$ 61.8 M
Market Cap
-0.44
P/E
INCOME STATEMENT
EFFICIENCY
Earnings Waterfall
Biomea Fusion, Inc.
| Revenue | 0 |
| Cost Of Revenue | 0 |
| Gross Profit | 0 |
| Operating Expenses | 144 M |
| Operating Income | -144 M |
| Other Expenses | -5.64 M |
| Net Income | -138 M |
Income Statement
Millions
| Dec-2024 | Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | |
|---|---|---|---|---|---|---|
| REVENUE | ||||||
| Revenue | 0 | 0 | 0 | 0 | 0 | 0 |
| GROSS PROFIT | ||||||
| Cost Of Revenue | 0 | 4.2 | 1.3 | 1.0 | 0.1 | 0 |
| Gross Profit | 0 | (4.2) | (1.3) | (1.0) | (0.1) | 0 |
| OPERATING INCOME | ||||||
| Operating Expenses | 144.1 | 126.1 | 83.6 | 41.7 | 5.3 | 1.2 |
| Selling, General and Administrative Expenses | 26.0 | 23.6 | 20.9 | 13.7 | 1.7 | 0.1 |
| Research and Development Expenses | 118.1 | 102.5 | 62.7 | 28.0 | 3.7 | 1.1 |
| Operating Income | (144.1) | (126.1) | (83.6) | (41.7) | (5.3) | (1.2) |
| PRE-TAX INCOME | ||||||
| Interest Income Expense | 0 | 0 | -- | 0 | 0 | -- |
| Total Other Income | 5.6 | 8.9 | 1.8 | 100 K | 3 K | 3 K |
| Pre-Tax Income | (138.4) | (117.3) | (81.8) | (41.6) | (5.3) | (1.2) |
| NET INCOME | ||||||
| Tax Provision | 0 | 0 | (1.8) | (0.3) | (0.2) | 1.2 K |
| Net Income | (138.4) | (117.3) | (80.0) | (41.2) | (5.3) | (1.2) |
| EPS | 3.83 | 3.44 | 2.73 | 1.73 | 0.5 | 0.11 |